Physician profile
Pickens A Patterson
NPI 1316926058
$6,392.99
in general payments reported to CMS, 2019-2025
29 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,472 · 2020: $3,108 · 2021: $522 · 2022: $23.41 · 2023: $75.67 · 2024: $192.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $267.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $267.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,915.00 | 2019-2024 | Wavewriter Alpha Prime 16 |
| Abbott Laboratories | $1,578.88 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $361.83 | 2019-2022 | |
| Biodelivery Sciences International, INC. | $201.95 | 2019-2021 | |
| Pfizer INC. | $194.07 | 2019-2021 | |
| Pacira Therapeutics, INC. | $166.61 | 2019-2020 | |
| Amgen INC. | $151.63 | 2019-2021 | |
| Horizon Therapeutics Plc | $125.03 | 2019-2020 | |
| Collegium Pharmaceutical, INC. | $118.22 | 2019-2023 | Xtampza, Belbuca |
| Redhill Biopharma INC. | $66.69 | 2020-2021 | |
| Scilex Pharmaceuticals INC. | $56.47 | 2021 | |
| Electronic Waveform Lab, INC. | $50.66 | 2019 | |
| Forte Bio-Pharma LLC | $46.30 | 2020-2021 | |
| Kaleo, INC. | $43.37 | 2019 | |
| Assertio Therapeutics, INC. | $41.91 | 2019 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertical Pharmaceuticals, LLC | $36.16 | 2019 | |
| Shionogi INC | $28.63 | 2019 | |
| Sentynl Therapeutics, INC. | $27.51 | 2019 | |
| Mdd US Operations, LLC | $25.02 | 2019 | |
| Daiichi Sankyo INC. | $22.86 | 2019 | |
| Masimo Corporation | $22.27 | 2023 | Patient Safetynet System |
| Novartis Pharmaceuticals Corporation | $19.78 | 2021 | |
| Radius Health, INC. | $17.58 | 2021 | |
| Almatica Pharma LLC | $14.39 | 2021 | |
| Nevro Corp. | $14.36 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $13.34 | 2019 | |
| Medtronic USA, INC. | $11.61 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $10.86 | 2019 | |
| Spr Therapeutics, INC | $10.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pickens Patterson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.